| scholarly article | Q13442814 |
| P50 | author | B Mark Evers | Q89810329 |
| P2093 | author name string | David S Watt | |
| Chunming Liu | |||
| Joseph B Zwischenberger | |||
| Aman Khurana | |||
| Roberto Gedaly | |||
| Francesc Marti | |||
| Lilia Turcios | |||
| Fanny Chapelin | |||
| Lilia M Kril | |||
| P2860 | cites work | Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer | Q26747750 |
| Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535 | Q27324314 | ||
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| Caught up in a Wnt storm: Wnt signaling in cancer | Q29617494 | ||
| Growth of human hepatoma cells lines with differentiated functions in chemically defined medium | Q29617962 | ||
| PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation | Q35324465 | ||
| N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells | Q35967478 | ||
| Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. | Q36247123 | ||
| Wnt/Frizzled signaling in hepatocellular carcinoma | Q36348260 | ||
| Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health. | Q38243334 | ||
| ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma | Q38651973 | ||
| Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways | Q39009114 | ||
| The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment | Q39321122 | ||
| PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation | Q39409543 | ||
| PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways | Q39615186 | ||
| Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hc | Q40284059 | ||
| Sorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function | Q47978539 | ||
| Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth. | Q49627330 | ||
| Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer. | Q50025648 | ||
| The Metabolism of Renal Cell Carcinomas and Liver Cancer | Q60628580 | ||
| Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinoma | Q64114789 | ||
| Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival | Q77626767 | ||
| WNT/β-catenin signaling and hepatocellular carcinoma | Q87469831 | ||
| An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt Inhibitors | Q91487876 | ||
| Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential Biomarkers | Q91807970 | ||
| Immune Therapy for Liver Cancers | Q92354127 | ||
| CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential | Q92407617 | ||
| Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis | Q96122767 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 31 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| metabolic network | Q2263094 | ||
| P304 | page(s) | 3013-3024 | |
| P577 | publication date | 2020-08-04 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Mitochondrial uncoupling and the disruption of the metabolic network in hepatocellular carcinoma | |
| P478 | volume | 11 |
Search more.